Earnings6 reported quarters · next on Dec 14, 2026
Earnings
Quarter
EPS
EPS expected
Revenue
Revenue expected
Result
Q1 FY2027reported Sep 10, 2026
$1.92
$1.74
$19.3B
$19.1B
EPS beatRevenue in line
Q4 FY2026reported Jun 10, 2026
$2.11
$1.96
$19.2B
$19.1B
EPS beatRevenue in line
Q3 FY2026reported Mar 10, 2026
$1.79
$1.70
$17.2B
$16.9B
EPS beatRevenue beat
Q2 FY2026reported Dec 10, 2025
$2.26
$1.64
$16.1B
$16.2B
EPS beatRevenue in line
Q1 FY2026reported Sep 9, 2025
$1.47
$1.48
$14.9B
$15.0B
EPS in lineRevenue in line
Q4 FY2025reported Jun 11, 2025
$1.70
$1.64
$15.9B
$15.6B
EPS beatRevenue beat
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag reads n/a only when a number is missing. Quarterly EPS is the figure set against the consensus, usually adjusted, so the quarters need not add up to the 12-month net income per share above. An estimate is a forecast made by analysts, not a company target.
Oracle expects fiscal second-quarter revenue growth of 30% to 34% and non-GAAP EPS of $1.85 to $1.93, excluding gains from Ampere booked in last year's second quarter.
Fiscal 2027 revenue outlook
At least $90 billion, up 34% year over year
Fiscal 2027 non-GAAP EPS outlook
$8.10
Fiscal second-quarter cloud revenue growth outlook
Written by GetSignal with AI from each earnings call; every brief quotes the executives' own words. Key facts are what the company said on the call, not our forecast. Not investment advice.
Each firm's latest price target on ORCL, newest first
Firm
Rating
Target
Action
Date
Stephens
Overweight
$213
Target set
Scotiabank
Sector Outperform
$205
Target set
Baird
Outperform
$215
Target set
Melius Research
Buy
$170
Target set
Wells Fargo
Overweight
$250
Cut from $280
Goldman Sachs
Buy
$206
Cut from $240
BMO Capital
Outperform
$195
Cut from $220
Stifel
Buy
$200
Cut from $220
Barclays
Overweight
$252
Raised from $250
Morgan Stanley
Equal Weight
$210
Raised from $207
Jefferies
Buy
$290
Cut from $320
UBS
Buy
$245
Cut from $285
CLSA
Hold
$145
Initiated
D.A. Davidson
Buy
$225
Target set
Wedbush
Outperform
$240
Cut from $275
Bernstein
Outperform
$325
Target set
Piper Sandler
Overweight
$225
Target set
Wolfe Research
Not stated
$225
Target set
Oppenheimer
Outperform
$275
Raised from $235
Evercore ISI
Outperform
$245
Target set
Cantor Fitzgerald
Overweight
$284
Raised from $229
RBC Capital
Sector Perform
$190
Raised from $160
Mizuho
Outperform
$320
Target set
Arete
Buy
$255
Target set
Deutsche Bank
Buy
$300
Target set
KeyBanc
Overweight
$300
Target set
HSBC
Buy
$382
Target set
Each firm's latest target from the past year, with the rating stated with its note or within three days of it. These are the firms' own views, not GetSignal's, and we do not endorse them. Not investment advice.
9 other firms rated ORCL in the past year with no current target listed here. Ratings and targets come from licensed market data providers. A target is listed only after its firm and company are confirmed against a report of the note. As of Nov 14, 2026.
Clayton M. Magouyrk’s pay as CEO came to $627.5M for fiscal 2026.
Executive
Salary
Stock awards
Other
Total
Clayton M. MagouyrkDirector and Chief Executive Officer
$942K
$0
$626.5M
$627.5M
Michael D. SiciliaDirector and Chief Executive Officer
$942K
$0
$255.7M
$256.6M
Lawrence J. EllisonExecutive Chair and Chief Technology Officer
$950K
$0
$130.1M
$131.0M
Mark HuraPresident, Global Field Operations
$772K
$0
$57.5M
$58.3M
Hilary MaxsonChief Financial Officer
$146K
$10.2M
$31.4M
$41.7M
Douglas KehringExecutive Vice President and Head of Operations
$800K
$16.7M
$512K
$18.0M
Stuart LeveyExecutive Vice President, Chief Legal Officer
$950K
$13.8M
$769K
$15.5M
The summary compensation table from the proxy statement for fiscal 2026, with titles as filed then. 1 executive who has since left the company is named in that filing and not shown here. Read the filing
13F filings13F positions as of Jun 30, 2026
Institutional holders
3,541 institutions reported Oracle shares in 13F filings for Jun 30, 2026.
Holder
Value
Shares
Shares vs prior qtr
% of shares out
BlackRock, Inc.
$21.3B
145,353,687
+1.4%
5.05%
Vanguard Capital Management LLC
$16.4B
111,788,001
+0.6%
3.88%
State Street Corp
$11.5B
78,645,193
+3.1%
2.73%
Vanguard Portfolio Management LLC
$8.4B
57,285,664
+1.0%
1.99%
Capital Research Global Investors
$5.8B
39,746,237
+23.7%
1.38%
Geode Capital Management, LLC
$5.7B
39,248,959
+0.8%
1.36%
Morgan Stanley
$4.5B
30,551,196
+4.9%
1.06%
FMR LLC
$3.8B
26,025,909
+13.7%
0.90%
Norges Bank
$3.7B
25,002,553
New
0.87%
Bank of America Corp
$3.5B
23,954,012
+55.7%
0.83%
JPMorgan Chase & Co.
$3.4B
22,899,905
-29.5%
0.80%
Goldman Sachs Group Inc
$3.1B
21,280,008
+41.9%
0.74%
A 13F reports long US equity positions and is filed within 45 days of the quarter end, so these are positions as they stood on Jun 30, 2026. New: not in this holder's prior 13F as reported; a change of filer ID can also show as new. For a manager's whole book see the fund directory. What a 13F covers and leaves out is explained in our guide to Form 13F.
6 of the 97 fund managers we track list ORCL shares among the largest positions in their latest 13F, filed for Q2 2026. A manager can hold it further down the book too, so this is a floor, not a count. Share of book is the position against the manager's whole disclosed 13F value.
One row is one filing, newest filing first. A filing that reported its trade in several tranches is summed, priced at the weighted average, and marked with its line count. Scheduled: set up in advance under a Rule 10b5-1 trading plan. The delay counts business days from the trade to the filing, the unit of Form 4's two business day deadline: weekends and federal holidays are skipped. How the filing itself works is explained in our guide to Form 4.
Other Form 4 activity (20)
Insider
Event
Shares
Date
Jeffrey HenleyVice Chairman
Tax withholding
3,529
Oct 23, 2026
Jeffrey HenleyVice Chairman
Option exercise
8,033
Oct 23, 2026
Maria SmithEVP, Chief Accounting Officer
Tax withholding
4,673
Oct 23, 2026
Maria SmithEVP, Chief Accounting Officer
Option exercise
8,926
Oct 23, 2026
Stuart LeveyEVP, Chief Legal Officer
Stock award
479
Oct 23, 2026
Stuart LeveyEVP, Chief Legal Officer
Tax withholding
6,130
Oct 23, 2026
Stuart LeveyEVP, Chief Legal Officer
Option exercise
12,497
Oct 23, 2026
Safra CatzChief Executive Officer
Tax withholding
2,550
Oct 23, 2026
Safra CatzChief Executive Officer
Option exercise
8,033
Oct 23, 2026
Michael D. SiciliaChief Executive Officer
Stock award
446,197
Oct 15, 2026
Maria SmithEVP, Chief Accounting Officer
Stock award
66,930
Oct 15, 2026
Stuart LeveyEVP, Chief Legal Officer
Stock award
104,113
Oct 15, 2026
Clayton M. MagouyrkChief Executive Officer
Stock award
446,197
Oct 15, 2026
Hilary B. MaxsonChief Financial Officer
Stock award
89,240
Oct 15, 2026
Jeffrey HenleyVice Chairman
Stock award
66,930
Oct 15, 2026
Mark HuraPres., Global Field Operations
Stock award
237,972
Oct 15, 2026
Safra CatzChief Executive Officer
Stock award
66,930
Oct 15, 2026
Lawrence Joseph EllisonDirector
Stock award
223,099
Oct 15, 2026
Maria SmithEVP, Chief Accounting Officer
Tax withholding
9,105
Sep 21, 2026
Maria SmithEVP, Chief Accounting Officer
Option exercise
5,506
Sep 20, 2026
Awards, option exercises, shares withheld to cover tax and gifts all file on the same form as a purchase or a sale. None of them is a decision to trade, so they sit here rather than beside the ones that are.
STOCK Act20 disclosures of 224 on record · median 23d of the 45 allowed
Congress trades in ORCL
Since the trade: the stock's move from its estimated entry price (a purchase) or estimated exit price (a sale) to its current price, the latest close we hold. Not the member's result.
-8.2%since the saleEstimated exit price $136.48, close on Thu Feb 5Current price $125.35, close on Fri Nov 13
Feb 5, 2026
Mar 9, 2026
32d
Estimated prices are the stock's closing price on the trade date. A disclosure gives a value band, not the price paid. Not investment advice. After a sale a positive figure means the stock kept rising after it. On an option line the prices are the stock's, never the option's: the premium is never disclosed.
A delay above 45 days is the gap between the dates on the report; we mark a filing late only after checking it.
"Not captured" means the band or the transaction type on the original report is missing from our data.
"Dates conflict" marks a row whose disclosure is dated before its trade on the record we hold. Both dates are printed as filed, and no prices or move are shown for that row.
The largest estimated position is in the $100,001 - $250,000 band. Estimate, as of Nov 12, 2026. Each position is modelled from the member's disclosed transactions and annual filings: the midpoint of each disclosed band, marked to the latest close we hold. It is a rough estimate of a reported position, not a figure from a filing, which is why it is shown as a band. Share of portfolio sets that estimate against the member's whole estimated public-stock portfolio.
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
On Form 4, code P is an open-market purchase and S an open-market sale; a sale marked scheduled was set up in advance under a Rule 10b5-1 plan. Awards, option exercises, tax withholding and gifts (A, M, F and G) are listed under Other Form 4 activity and never counted as either.
A STOCK Act disclosure gives each trade as a band of dollar values, which we do not narrow, and is due within 45 days of the trade. An option is described by its underlying company's name; its row says it is an option.
What the filings on ORCL show and how current they are.
Are insiders buying or selling ORCL?
Across the 5 most recent open-market filings shown here, 1 was a purchase and 4 were sales. 3 were scheduled in advance under a Rule 10b5-1 plan.
Which members of Congress have traded ORCL?
Ro Khanna, Michael A. Rulli, Alan Armstrong, Sheldon Whitehouse, Jared Moskowitz and Michael T. McCaul disclosed ORCL transactions in the filings shown here.
Which members of Congress hold ORCL?
19 members of Congress report a position in ORCL in the estimate we hold as of Nov 12, 2026. The three largest estimated positions belong to Cliff Bentz, Sheldon Whitehouse and Thomas H. Kean, Jr. The estimate is built from disclosed transactions and annual filings, so it is shown as a band rather than a figure from a filing.
Is ORCL in the S&P 500 or the Nasdaq 100?
Oracle Corporation is a current member of the S&P 500, per the membership list we hold as of Nov 14, 2026. Current members of either index get a page here whatever their filing history.
How quickly are ORCL trades disclosed?
Insider filings on this page reached the public a median of 1 business day after the transaction (weekends and federal holidays skipped), against the two business days Form 4 allows. Congressional disclosures took a median of 23 days, against the 45 the STOCK Act allows.